Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 19 of 19 for “"LGMD2B"”.
-
Galectin-1: Development of a Novel Protein Therapy for LGMD2B
… weakness. Limb-Girdle Muscular Dystrophy 2B (LGMD2B) is a subset of muscular dystrophy caused by mutations in the DYSF gene, which encodes for dysferlin protein and has an incidence of 1/100,000-1/200,000 people, or 1/300 people of Libyan Jewish descent. Since there is no effective treatment …
-
Galectin-1 Improves Sarcolemma Repair and Decreases the Inflammatory Response in LGMD2B Models
Limb-girdle muscular dystrophy type 2B (LGMD2B) is caused by mutations in the dysferlin gene, resulting in non-functional dysferlin, a key protein found in muscle membrane. Treatment options available for patients are chiefly palliative in nature and focus on maintaining ambulation. Our hypothesis …
-
Enhancing Muscle Health and Modulating Immune Response with Galectin-1 in LGMD2B/R2 Models
Limb-Girdle Muscular Dystrophy Type 2B/R2 (LGMD2B/R2) is a type of dysferlinopathy, a progressive muscle-wasting disorder caused by mutations in the dysferlin gene. Hallmarks of the disease include chronic inflammation, impaired muscle regeneration, and eventual muscle degeneration. Currently, no …
-
Effects of thermoneutrality on dysferlin-deficient muscular dystrophy
Limb-Girdle Muscular Dystrophy (MD) Type 2B (LGMD2B) is a rare form of MD caused by mutations in the dysferlin (DYSF) gene. As an autosomal recessive disorder, LGMD2B can occur in both males and females and is characterized by progressive muscle wasting, eventually leading to ambulatory …
-
Komplement-vermittelte Zellschädigung als Pathomechanismus der Dysferlin- defizienten Gliedergürteldystrophie
… Gliedergürteldystrophie Typ 2B (LGMD2B) gehört zu den hereditären Muskelerkrankungen, die zu schwerwiegender progredienter Schwäche der proximalen (LGMD2B) Skelett-Muskulatur führen. Histologisch finden sich neben den typischen Zeichen der Muskeldystrophie entzündliche zelluläre …
-
Caracterização clínica e molecular das miopatias hereditárias no Brasil
… sobrevida para incapacidade física nas LGMD2A, LGMD2B e sarcoglicanopatias foram construídas e avaliaram-se as progressões clínicas de acordo com o sexo e genótipo. No segundo estudo, um estudo transversal de casos índices consecutivos com suspeita clínica de HM num centro único especializado em …
-
Korrelation von Genotyp und Phänotyp sowie Beteiligung des Immunsystems bei Patienten mit Dysferlin-defizienter Muskeldystrophie
… Gliedergürtel-Muskeldystrophie 2B (LGMD2B; OMIM #253601) und Miyoshi Myopathie (MM; OMIM #254130). Außerdem spielen die Beteiligung des Komplementsystems einerseits und die Bildung von Amyloid-Fibrillen andererseits eine Rolle in der Pathogenese der Dysferlin- defizienten …
-
Limb girdle muscular dystrophy in unique Manitoba populations
… known loci in these families excluded all but 'LGMD2B'. Haplotype analysis of the 'LGMD2B' locus on chromosome 2p13 revealed that individuals affected with either LGMD or distal myopathy were homozygous for a single haplotype, suggesting that they would also be homozygous for the disease-causing …
-
Dysferlin-defiziente Muskeldystrophie:Verlaufsstudie des Mausmodells im 7T-MRT
… der Gliedergürtelmuskeldystrophie Typ 2B (LGMD2B) sind Mutationen im Dysferlin-Gen (DYSF), welches das Protein Dysferlin kodiert. Dysferlin ist ein physiologisches Membranreparierprotein, welches bei Rissen im Sarkolemma aktiviert wird. Ohne DYSF unterbleibt eine Reparatur der Defektstelle …
-
Disferlinopatía: cuantificación clínica evolutiva y correlación fenotipo-genotipo
… fenotipos diferentes en las disferlinopatías: LGMD2B, MM y DACM. Los más frecuentes y, por tanto, mejor definidos son la LGMD2B y la MM. Es un hecho ampliamente descrito la heterogeneidad genética de las disferlinopatías, ya que una misma mutación puede determinar fenotipos diferentes. Desde el …
-
Effects of hyperlipidemia on dysferlin- and dystrophin-deficient muscular dystrophies in double-disease mouse models
… (Dysf-KO) model of limb-girdle type 2B MD (LGMD2B) and the dystrophin-null (mdx) model of Duchenne MD (DMD) were crossed with apolipoprotein E-KO (ApoE-KO) hyperlipidemia model to generate Dysf-ApoE and Mdx-ApoE double-knockout mice (DKO). To further confirm the effects vascular disease on …
-
RNA-based therapies for dysferlinopathies
… manifests as limb girdle muscular dystrophy 2B (LGMD2B) and Miyoshi myopathy 1. Two strategies of pre-mRNA cis-splicing modification for DYSF gene repair were pursued in the presented thesis, (i) spliceosome-mediated pre-mRNA trans-splicing (SMaRT) by an engineered pre-mRNA trans-splicing …
-
Exon skipping as a therapeutic strategy in dysferlinopathy
… limb-girdle muscular dystrophy type 2B (LGMD2B) or Miyoshi myopathy (MM). It is caused by mutations in the dysferlin gene. Dysferlin is a membrane protein expressed in skeletal muscle. It is responsible for the repair of sarcolemma microlesions produced by muscle contractions. A …
-
Características clínicas e genéticas da distrofia muscular de cinturas tipo 2G/R7-teletonina na população brasileira
… como a LGMD2A/R1 relacionada à calpaína 3 e LGMD2B/R2 relacionada à disferlina, sendo possível, enquanto não há caracterização de sua história natural por desfechos de avaliação clínica, considerar comportamento similar ao dessas outras formas. Além disso, assim como descrito para LGMD2B/R2, …
-
Πρωτοπαθής και δευτεροπαθής μεταβολή της έκφρασης επιλεγμένων μυϊκών πρωτεϊνών σε ασθενείς με μυϊκή δυστροφία
… (α-sarcoglycan), 1% LGMD2Ε (β-sarcoglycan), 6% LGMD2B (dysferlin) and 6% LGMD1C (caveolin-3). CONCLUSION: These data suggest that although dysferlin is not an integral part of the dystrophin glycoprotein complex, its expression is altered in Duchenne muscular dystrophy.Calpainopathy is the most …
-
Molekulare Diagnostik der Dysferlinopathie
… Die Gliedergürtel-Muskeldystrophie Typ 2B (LGMD2B), die Miyoshi Myopathie (MM) und die distale anteriotibiale Myopathie (DMAT). Betroffen sind initial dementsprechend unterschiedliche Muskelgruppen. Um ein zuverlässiges Diagnosesystem zu etablieren und einen Beitrag zur klinischen und …
-
Bioinformatics tools for the systems biology of dysferlin deficiency
… (Limb Girdle Muscular Dystrophy type 2B (LGMD2B), Miyoshi myopathy and distal myopathy with tibialis anterior onset (DMAT)). We have developed various tools and pipelines that can be applied towards a bioinformatics functional analysis of omics data in muscular dystrophies and …
-
A cell-based gene therapy approach for dysferlinopathy using Sleeping Beauty transposon
… (MM), limb girdle muscular dystrophy 2B (LGMD2B) and distal anterior compartment myopathy (DACM) are rare autosomal recessive muscle disorders caused by mutations in dysferlin. They are encompassed by the term dysferlinopathy and affect the proximal and/or distal muscles of the limbs. …
-
Patient-reported Clinical Care Experiences while Navigating the Progression of Dysferlinopathy (Limb-Girdle Muscular Dystrophy 2B/R2)
Dysferlinopathy is an ultra-rare, autosomal recessive form of limb-girdle muscular dystrophy (LGMD) with no existing treatments or disease-specific clinical care guidelines. Efforts have been made to prepare for future interventional trials of dysferlinopathy through preclinical research, natural …